Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma
| Autor: | Sandra Nora González-Díaz, Rosalaura Virginia Villarreal-Gonzalez, C. De Lira-Quezada, G K Rocha-Silva, O Vidal-Gutierrez, V M Oyervides-Juarez |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Oncology
Male medicine.medical_specialty Lung Neoplasms Bevacizumab Drug-Related Side Effects and Adverse Reactions medicine.medical_treatment Immunology Adenocarcinoma Antibodies Monoclonal Humanized Severity of Illness Index Drug Hypersensitivity Antineoplastic Agents Immunological Atezolizumab Internal medicine medicine Immunology and Allergy Humans Anaphylaxis Desensitization (medicine) Lung business.industry Middle Aged medicine.disease medicine.anatomical_structure Treatment Outcome Desensitization Immunologic business medicine.drug |
| Zdroj: | Journal of investigational allergologyclinical immunology. 31(3) |
| ISSN: | 1018-9068 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|